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Abstract
Introduction This review article addresses the best evidence
currently available for the effectiveness of injection therapy
for musculoskeletal conditions involving the peripheral joints.
The research is presented by anatomical region and areas of
controversy and the need for additional research are identified.
Discussion Randomized controlled trials, meta-analyses
and systematic reviews are lacking that address the
effectiveness of therapeutic injections to the sternoclavicu-
lar, acromioclavicular, ankle and foot joints. No research
studies of any kind have been reported for therapeutic
injections of the sternoclavicular joint. With the exception
of the knee, possibly the hip and patients with inflammatory
arthropathies, research does not unequivocally support the
use of therapeutic joint injections for most of the peripheral
joints, including the shoulder. Additionally, controversy
exists in some areas as to whether or not corticosteroids
provide better outcomes compared to local anesthetic
injections alone.
Conclusion When viscosupplementation injections are
compared to corticosteroids in patients with osteoarthritis
of the knee, the evidence supports the use of viscosupple-
mentation for more prolonged improvement in outcomes,
with corticosteroids being good for short-term relief.
Keywords Therapeutic injections . Joint injections .
Corticosteroid injections . Viscosupplementation .
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Introduction
Amongst the most common conditions presenting to
primary health care practitioners are those involving the
musculoskeletal system. Treatment of these various
conditions is often costly with the effectiveness of many
of the treatments not necessarily substantiated according
to the criteria of evidence-based medicine. Conservative
care is provided to most patients initially, consisting of
several options such as exercise, educational interven-
tions, manipulation or mobilization, various physical
therapy treatments, or pharmacological interventions [1].
If conservative measures fail to alleviate the symptoms,
many patients are then referred for imaging-guided
diagnostic or therapeutic joint injections. The purpose of
a diagnostic joint injection is to determine whether or not
a particular joint is the source of the patient’s complaint.
This injection delivers a local anesthetic with a particular
length of action with the patient response compared to the
expected action of the anesthetic. Therapeutic joint
injections add a corticosteroid in addition to the local
anesthetic to address any inflammation occurring and
prolong the therapeutic effect [2–6].
A search of the literature was performed, focusing
primarily on systematic reviews, meta-analyses and
randomized controlled clinical trials (RCTs) to evaluate
the level of evidence concerning the effectiveness of
therapeutic joint injections into the various peripheral
joints of the extremities, identify best practice and to
determine specific areas where further research is
needed. Retrospective and prospective cohort studies and
case series studies were included in the absence of other
evidence. The search strategy utilized PubMed, including the
‘links’ and ‘limits’ functions specifically for reviews, meta-
analyses, randomized controlled trials and clinical trials.
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Additionally, the Cochrane database, Google scholar and
references for articles retrieved were searched.
Systematic reviews, meta-analyses and high quality RCTs
are considered by the traditional scientific community as ‘best
evidence’ and therefore exclude evidence from practical
experience, expert opinion, cohort studies and guidelines.
Therefore, the conclusions drawn from this ‘best evidence’
approach may not reflect positively on some commonly
performed therapeutic injections. This indicates an interest for
further research studies, along with perhaps reconsideration as
to what indeed constitutes ‘best evidence’ in interventional
pain management.
Upper extremity
This review will focus little on the use of therapeutic
corticosteroid injections for the inflammatory arthropathies,
particularly rheumatoid arthritis (RA) and juvenile chronic
arthritis, as the evidence in support of this treatment, at least
for short term improvement, is fairly strong [7–10]. Table 1
summarizes the research implications for therapeutic joint
injection of the extremities.
Shoulder (glenohumeral joint and subacromial injections)
In spite of the fact that therapeutic corticosteroid injections
are commonly used to treat a variety of shoulder conditions,
including tendinopathies, bursitis, impingement syndrome,
adhesive capsulitis, rotator cuff tears and arthritis, two
systematic reviews and two recent meta-analyses found
limited evidence to support the effectiveness of this
treatment [11–14]. Problems include heterogeneity in the
methods used as well as small sample sizes [11].
Two areas where these therapeutic shoulder injections may
be effective include subacromial injection for rotator cuff
disease (tendinopathy) and intra-articular injection for adhe-
sive capsulitis. However, the evidence supporting the use of
steroids for these conditions remains controversial [12, 13],
especially for long-term improvement. For rotator cuff
disorders, corticosteroids appeared less effective for function
than other treatments combined, and appear to be no more
effective than NSAIDs (non-steroidal anti-inflammatory
drugs) [12] and local anesthetics [15], even with longer-
term follow-up. One problem with the assessment of the
effectiveness of shoulder injections is the common lack of a
specific diagnosis. Distinguishing a rotator cuff tear from
a tendinopathy is important as there is little evidence to
support therapeutic injections for tears [12, 13], but some
evidence to support their use for tendinopathy [14]. A meta-
analysis done in 2005 on subacromial injections for rotator
cuff tendinitis reported that the numbers needed to treat
ranged from 1.4–2.2 patients [14].
Shoulder (acromioclavicular joint)
No systematic reviews, meta-analyses or RCTs were found on
therapeutic injections for the acromioclavicular (AC) joint.
One recent prospective cohort study with a 5-year follow-up
was found however that investigated this procedure on
patients with primary AC joint arthritis [16]. This group of
researchers reported that injection of corticosteroid into the
AC joint is an effective treatment for primary isolated
osteoarthritis (OA) and that this improvement of approxi-
mately 25% reduction in symptoms lasts at least 12 months.
Although the therapeutic effect diminished over time, benefit
was felt for up to 5 years. This study highlights the
importance of having a specific diagnosis in order to
determine which patients (i.e. subgroups) may benefit from
a particular procedure. While only patients with osteoarthritis
were included in this study, the results are meaningful to
physicians and patients with this diagnosis in making
treatment decisions. Similarly, a larger prospective cohort
study on patient responses to a single therapeutic AC joint
injection looked at specific AC abnormalities associated with
AC osteoarthritis as visualized on MR images and compared
these abnormalities with patient responses to injection.
Specific abnormalities associated with a better patient
response included hypertrophy of the joint capsule and
osteophytes projecting inferiorly from the joint [17]. How-
ever, pain response was only measured at one time point,
15 min post injection. No conclusions can be made about
long-term effectiveness. Finally, a third prospective cohort
study on patients with osteoarthritis of the AC joint found
that both pain and shoulder range of motion improved after a
single injection of corticosteroid to the joint [18]. Again this
study only looked at short-term outcomes with improvement
still evident at 2 weeks post injection.
Shoulder (sternoclavicular joint)
No investigations on therapeutic injections targeting the
sternoclavicular joint were found, although this procedure
is referred to in papers outlining treatment options for joint
pain. While the sternoclavicular joint is not a common
source of pain compared to the other joints of the shoulder
region, it would be worthwhile to begin to establish
outcomes on patients receiving this treatment.
Elbow-lateral epicondylitis
A meta-analysis done in 2008 looked at 20 RCTs
investigating the effectiveness of corticosteroid injections
for the treatment of shoulder and elbow tendinopathy [12].
As reported for the shoulder, there is evidence of the short-
term effectiveness (1–3 weeks and 4–8 weeks) of these
injections for tendonitis, but at longer term follow-up,
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steroid injections were inferior to other treatments for
function. Additionally, NSAIDs were just as effective as
steroid injections for improvement in the short term.
Three RCTs published after the meta-analysis was
conducted provide more insight into the use of corticoste-
roid injections for lateral epicondylitis. For patients wishing
an early return to activities such as high level athletes, an
injection of a steroid plus local anesthetic provided better
relief compared to physiotherapy treatment (PT), no
treatment, and a combination of PT and local injection in
the 142 patients investigated [19]. Dogramaci et al. [20]
compared three different injection techniques on 75 patients
and found that all three treatments provided good or
excellent (as reported by the patient) outcomes at 6-month
follow-up in 92–100% of the patients. The three injection
techniques included (1) injection of steroid (triamcinolone)
plus a local anesthetic; (2) injection of local anesthetic
alone with the so-called ‘peppering’ technique (i.e. multiple
local injections consisting of withdrawing slightly after
each injection, moving the needle, injecting again without
emerging from the skin); and (3) injection of steroid
(triamcinolone), a local anesthetic plus the ‘peppering’
technique. While the authors’ conclusion was that the
peppering technique combined with corticosteroid injec-
tions and local anesthetic produced better clinical results in
patients with lateral epicondylitis, a close look at their
results revealed that although there was a statistically
significant difference between two of the treatment groups,
this difference was so small as to be not clinically relevant.
Patients in all three treatment groups reported a value of
less than 1 on the VAS at 6-month follow-up.
Further complicating this issue is the study byLindenhovius
et al. [21] on 64 patients with lateral epicondylitis. Their RCT
looked at two different treatments, either an injection with a
corticosteroid or a ‘placebo’ injection of 1% lidocaine. They
found that the corticosteroid injection (dexamethasone) did
not improve the apparently self-limiting course of lateral
epicondylitis compared to the placebo injection. However, it
can be questioned whether or not a local anesthetic is actually
a true placebo, especially in light of previous research in the
spine and shoulder suggesting that patients may respond
equally well to local anesthetic injections as compared to
steroid injections [15, 22, 23].
The evidence to date suggests that injections for lateral
elbow pain appear to be successful for short-term pain relief,
but may be worse for long-term functional outcomes.
Comparison to less invasive forms of treatment needs further
exploration.
Wrist and hand
Corticosteroid injections for rheumatoid arthritis, juvenile
idiopathic arthritis or other inflammatory arthropathies is
fairly well established [7–10, 25], but not discussed in detail
in this article. The mean duration of remission has been
reported as 23.1 months [24], with the additional use of wrist
splints providing no increased therapeutic benefit [10].
Carpal tunnel syndrome
The recent Cochrane review of local corticosteroid injec-
tions for carpal tunnel syndrome [26] compared these local
injections with local placebo injections, systemic steroid
injections or other non-surgical treatments and found 12
studies that met their inclusion criteria for review. Cortico-
steroid injections were superior to placebo injections, oral
corticosteroids, or systemic corticosteroid injections for up
to 1 month post treatment. However, local corticosteroid
injection does not improve outcomes compared to either
anti-inflammatory treatment combined with wrist splinting
after 8 weeks or compared to Helium-Neon laser treatment
after 6 months. Additionally, more than 1 local injection
does not add any clinical benefit.
While a few studies support the use of splints for carpal
tunnel syndrome, patient compliance with this treatment
appears to be a problem. Therefore, the use of a single local
corticosteroid injection in the short-term management of
carpal tunnel syndrome is supported, with patients strongly
encouraged to use night splints for long-term management
[27].
Stenosing tenosynovitis including de Quervain’s disease
The best evidence available addressing this issue is a
pooled quantitative literature evaluation including 459
wrists done in 2003 [28]. The studies were descriptive
and compared patient outcomes before and after treatment,
or RCTs comparing one treatment method with another.
The conclusions were that the best treatment for stenosing
tenosynovitis is corticosteroid injection alone, with an 83%
cure rate. The cure rate for this treatment, (defined as a
complete resolution of symptoms), appears to far exceed
other therapeutic modalities such as injection plus splint,
splint alone, rest or NSAIDs. Two RCTs were also found on
this topic, but both studies used corticosteroid injections
(triamcinolone) as a treatment for all patients, only
randomizing patients to receive various additional therapies
as well as the corticosteroid injection [29, 30]. The
conclusions from these RCTs are that supplementing
patients with oral NSAIDS or adding an extra drug to
reduce ‘flare reactions’ (delayed post-injection transient
increase in pain) has no benefit over corticosteroid
injections alone. Between 67 and 68% of patients reported
substantial improvement after a single injection at 3-week
follow-up and 95% of patients were improved, (including
up to 4 injections), at approximately 1-year follow-up.
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Improvement was defined as complete resolution of
tenderness over the radial styloid process, complete
resolution of pain with resisted thumb abduction and
extension, a negative Finkelstein test and at least 90%
improvement in the pain score.
Wrist/hand: osteoarthritis of the first carpometacarpal joint
While no systematic reviews or meta-analyses were
found for most individual joints in the hand or wrist,
two RCTs looked at osteoarthritis of the first carpo-
metacarpal (CMC) joint, a common target site for this
condition [31, 32]. Both studies compared hyaluronic acid
as a therapeutic injectate to corticosteroids in a total of 80
patients. The results demonstrate that both drugs are
effective, although different corticosteroids were used in
each of the studies (triamcinolone or methylprednisolone
acetate). The steroids showed a faster onset of pain relief
with a maximum effect at 2 and 3 weeks after initiation of
treatment. Hyaluronic acid seemed to be the better choice
with slight to moderate superiority in almost all of the
assessed clinical parameters (pain relief, lateral pinch (key
grip) strength, pulp pinch power, radial abduction,
swelling, heat) after 6 months. Patients injected with
hyaluronic acid reported a 56% decrease in the VAS score
at 26 weeks compared to only a 22.6% decrease in the
VAS for patients injected with the corticosteroid [31].
Lower extremity
Hip osteoarthritis
Although therapeutic injections into the hip joint have been
used for many years, no systematic reviews or meta-analyses
were found. Three fairly recent prospective, double-blinded
RCTs [33–35] were done however. The most recent of these
RCTs involved 52 patients with randomization into either a
corticosteroid or a placebo injection (bipuvicaine) group
[35]. Clinically meaningful improvements in the Western
Ontario and McMaster Universities OA Index (WOMAC)
score were reported by the corticosteroid group, with 49.2%
of patients experiencing at least a 50% reduction in their pain
score compared to only 2.5% reduction for the placebo
group. These effect differences lasted at least 2 months.
Another larger RCT by Kullenberg et al. [34] with
similar results looked at hip OA patients who experienced
pain at rest as well as upon weight bearing for at least the
previous 4 weeks. Two groups were compared with 40
patients receiving an imaging-guided injection of cortico-
steroid into the hip while the other 40 patients received a
local anesthetic into the hip. Several outcome measures
were evaluated with a follow-up of 12 weeks. All outcome
measures demonstrated significant improvement for the
corticosteroid group of patients, particularly pain at rest
with >50% improvement on the VAS at 3 weeks post
injection. Range of motion significantly improved in all
directions, particularly in internal rotation, but no specific
numbers were provided. There was no significant im-
provement in pain or functional ability in the patients
treated with anesthetic. The last of these three RCTs
compared corticosteroid injections into the hip joint with
hyaluronic acid (HA) and placebo (saline) injections and
found that corticosteroids were superior to either of the
other two injections, particularly at 2 weeks and for ‘pain
on walking’, but the effect was short lived and gone by the
3 month follow-up. The conclusion of that study is that
steroids are good for acute flair-ups of osteoarthritis and
rheumatoid arthritis.
An older prospective cohort study [36] compared
osteoarthritis and rheumatoid arthritis patients for their
response to corticosteroid injections into the hip. Once
again, the effects were significant pain relief, particularly
night pain, but only for short periods of time. No difference
in pain relief between osteoarthritis and rheumatoid arthritis
patients was observed, but patients with a more hypertro-
phic form of arthritis experienced significantly more pain
relief compared to patients with an atrophic (associated
with chondrocalcinosis and more rapid progression) form.
Based on these studies, it appears that corticosteroid
injections into the hip do provide short-term improvement
in pain and function (2–3 months), particularly for night
pain, but that they are not effective for long-term pain
relief. Side effects may occur and have to be taken into
consideration. Osteonecrosis of the femoral head is a
known side effect of particularly oral corticosteroids, but
may also occur with joint injections, and there is the
additional question as to whether or not steroid injections
may further increase the damage to articular cartilage [37].
The injection of hyaluronic acid and similar compounds,
also known as viscosupplementation, into the joints of patients
suffering from osteoarthritis, particularly in the knee, is
receiving increasing attention. The goal of treatment is not
only relief of symptoms, but perhaps improvement in the
articular cartiligenous structure. The use of viscosupplemen-
tation in the hip is not as substantiated however. One recent
systematic review, published in 2008 [38], evaluated the level
of evidence in support of this treatment. While 16 articles
were included in this review, with a total of 509 patients, the
quality of the included studies (according to the principles of
evidence-based medicine) was not such that definitive
conclusions could be made. Thus, the impression is that
viscosupplementation, performed using imaging guidance,
seems an effective treatment for patients with hip OA, but at
this point in time, cannot be recommended as standard
therapy until more studies are done.
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Knee osteoarthritis
More evidence is available for therapeutic injections into
the knee than for any of the other peripheral joints. The best
evidence is contained in three recent systematic reviews
evaluating both corticosteroid and viscosupplementation
injections for patients with osteoarthritis as well as a meta-
analysis of viscosupplementation for OA patients [39–42].
The evidence supporting the use of corticosteroid injections
for patients with OA is well established for short-term
benefits, but as in other joints, longer-term benefits are not
confirmed [39]. The corticosteroid triamcinolone hexaceto-
nide was superior to betamethasone for pain reduction up to
4 weeks with the relative risk (RR) of 2.00 (95%
confidence interval 1.10–3.63).
The evidence supporting the use of viscosupplementation
using hyaluronan and hylan products demonstrates that this is
an effective treatment for OA of the kneewith improvement of
pain, function and patient global assessment, particularly pain
on weight bearing at 5–13 weeks after injection [40–42].
Patients’ pain levels decreased by around 50% while their
function improved from 9% at baseline to 32% during the 5–
13 weeks after injection. There appears to be considerable
variation between products [42]. Comparing corticosteroid
injections with viscosupplementation injections consistently
shows that the hyaluronic acid products, while slower in
onset of action, have a more prolonged effect compared to
the corticosteroids [39, 40].
Ankle and foot
Little published evidence supporting the use of therapeutic
joint injections currently exists for the foot and ankle region.
There are no systematic reviews or meta-analyses. The only
RCT found for the ankle region compared a local anesthetic to
saline for the relief of ankle pain after an arthroscopic
procedure [43]. A small but prospective cohort study
followed 18 patients (36 joints) who had either OA or RA
for 1 year using a validated, region specific questionnaire,
after intra-articular corticosteroid injection [44]. This study
found a statistically significant improvement up to 6 months
post-injection, with those patients showing the most im-
provement at 2 months also having the most beneficial
response at 1 year. However, in general, maximal improve-
ment was at 4 weeks, similar to studies on other joints, and
declined over time. The use of viscosupplementation was
also investigated in 75 patients with OA of the ankle in one
prospective clinical trial (not RCT) with a 6-month follow-up
[45]. After 5 weekly injections most patients experienced
significant improvement in both pain and function, starting
as early as 1 week after the fifth injection, with 86.7% of
patients reporting satisfaction with treatment at 6 months.
Adverse events were rare and all outcome measures other
than range of motion (ankle osteoarthritis scale, American
orthopaedic foot and ankle society ankle/hindfoot scores,
patients’ global satisfaction) improved.
First metatarsophalangeal joint
A well-designed RCT, using a placebo control group, is
planned to evaluate the efficacy of viscosupplementation
for treatment of OA involving the first metatarsophalangeal
(MTP) joint of the foot [46]. However, this trial has not
been completed and thus data is not available. A previously
performed RCT comparing viscosupplementation with
intra-articular corticosteroid injection to this same joint
found that while both injectates produced significant
improvements in pain at rest, pain with palpation and pain
on passive mobilization, only the patients receiving
hyaluronate (viscosupplementation) had decreased pain
with walking. As in other studies evaluating hyaluronate,
the positive effects of treatment were longer lasting for
viscosupplementation compared to corticosteroids [47]. The
VAS score for the viscosupplementation group decreased
from a mean baseline score of 62.2–26.2 mm at day 84,
while the corticosteroid group decreased from a mean
baseline score of 58.7–34.1 mm at day 84. Therefore, the
current evidence suggests that there is a role for both
corticosteroid and viscosupplementation injections into the
first MTP joint of the foot, but the effects are more
enduring with hyaluronate.
Possible weaknesses of evidence-based medicine
There is some debate whether or not RCTs (which then lead
on to systematic reviews and meta-analyses) should be the
gold standard for research into interventional pain medicine
techniques [44, 48], especially from an ethical perspective.
Large well-designed prospective observational studies may
more closely resemble the actual patient population,
making the evaluation of subgroups more feasible [48].
One can argue that perhaps RCTs should not be the only
evidence used in systematic reviews to evaluate the
effectiveness of interventional pain therapies. Furthermore,
research studies reporting patient outcomes for interven-
tional therapies should be easy to interpret and should assist
the radiologist or clinician to explain expected results to
patients [49, 50]. Reporting of p values may not be optimal
for this purpose. The proportion of patients who signifi-
cantly improve with treatment, confidence intervals as well
as the ‘numbers needed to treat’ are more appropriate
statistics to report [49, 50]. Easily understood research
results, such as the percentage of patients who significantly
improve with a particular therapeutic injection, should lead
to more appropriate referrals, optimal injection technique
and better outcomes for the patients.
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Conclusions
With the exception of the knee, possibly the hip and
patients with inflammatory arthropathies, additional re-
search evidence is required regarding the use of therapeutic
joint injections from the point of view of evidence-based
medicine. However, for most of the peripheral joints,
including the shoulder, current evidence looks promising
based on cohort studies and cross-sectional studies. Contro-
versy exists in some areas as to whether or not corticosteroids
provide better outcomes compared to local anesthetic injec-
tions alone. In some joints, viscosupplementation may
provide more prolonged improvement, with corticosteroids
good for short-term relief.
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